TB-500, derived from Thymosin Beta-4, complements BPC-157 by promoting systemic healing through cell migration, reducing inflammation throughout the body, and supporting new blood vessel formation
The risk profile, the side effect picture, and the lack of medical indication make it a different conversation than the recovery, metabolic, and immune peptides above
Our platform helps you determine when to increase doses, when to hold current dose, how to manage breakthrough nausea, optimal maintenance dosing after weight loss, and reconstitution calculations for research peptides
*These statements have not been evaluated by the FDA and are not intended to treat or cure any disease
What can IV therapy help with